TS

Taysha Gene Therapies IncNASDAQ TSHA Stock Report

Last reporting period 30 Jun, 2024

Updated 19 Sep, 2024

Last price

Market cap $B

0.441

Micro

Exchange

XNAS - Nasdaq

View Full Company Analysis

Taysha Current ratio

2.2

Last period Current ratio


What is Current ratio ?

Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.

What is Current ratio ?

Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.

What is Current ratio of Taysha Gene ?

Taysha Gene`s Current ratio for the last twelve months ended 2024-06-30 is 2.2

View Full Company Analysis